Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
10.1093/jac/dku379 J
Mounjaro Shortage resolved Available 2.5 mg/.5 mL 3 recent reports Shortage resolved according to the FDA but we're receiving reports of supply issues
Currently, the effects of 2.4 mg semaglutide once weekly are being explored in 1200 participants with biopsy-confirmed NASH in a Phase III clinical trial with a combined primary endpoint of resolution of NASH without worsening fibrosis, improvement in liver fibrosis without worsening of steatohepatitis, and time to first liver-related clinical event (NCT04822181) (see Table 2)
Note that TRIUMPH-3 is the cardiovascular-disease population, not the diabetes trial
Clinical Cancer Research 31(6):1002-1015, 2025
US$ 28.34
US$ 22.36
US$ 25.55
US$ 28.33
